Daphne Koller
PhD
CEO and Founder
👥Biography 个人简介
Daphne Koller founded insitro to apply machine learning to drug discovery including oncology therapeutics, integrating high-content screening with computational biology at industrial scale. Her foundational work on probabilistic graphical models has influenced virtually all statistical approaches used in cancer genomics and biomarker discovery. She has advanced the paradigm of data-driven drug development that is transforming cancer therapeutic discovery.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 Daphne Koller 的研究动态
Follow Daphne Koller's research updates
留下邮箱，当我们发布与 Daphne Koller（insitro）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment